$KPTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Karyopharm Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Karyopharm Therapeutics Inc.. Get notifications about new insider transactions in Karyopharm Therapeutics Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 09 2018 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
Dec 20 2017 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 10,000 | 2,640 | 32,424 | |
Dec 20 2017 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 9.16 | 10,000 | 91,553 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
Dec 20 2017 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
Dec 20 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 32,424 | |
Dec 20 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 9.16 | 10,000 | 91,553 | 512,143 | 522.1 K to 512.1 K (-1.92 %) |
Dec 20 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 522,143 | 512.1 K to 522.1 K (+1.95 %) |
Dec 13 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Option Exercise | M | 6.54 | 17,000 | 111,180 | 23,000 | |
Dec 13 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 9.59 | 644 | 6,173 | 11,381 | 12 K to 11.4 K (-5.36 %) |
Dec 13 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 9.93 | 16,356 | 162,443 | 12,025 | 28.4 K to 12 K (-57.63 %) |
Dec 13 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Buy | M | 6.54 | 17,000 | 111,180 | 28,381 | 11.4 K to 28.4 K (+149.37 %) |
Dec 13 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 10.88 | 10,042 | 109,256 | 11,381 | 21.4 K to 11.4 K (-46.87 %) |
Dec 08 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | M | 0.26 | 10,000 | 2,640 | 29,394 | |
Dec 08 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 10.39 | 10,000 | 103,903 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
Dec 08 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
Dec 08 2017 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | M | 0.26 | 10,000 | 2,640 | 29,394 | |
Dec 08 2017 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 10.39 | 10,000 | 103,903 | 713,510 | 723.5 K to 713.5 K (-1.38 %) |
Dec 08 2017 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Buy | M | 0.26 | 10,000 | 2,640 | 723,510 | 713.5 K to 723.5 K (+1.40 %) |
Nov 09 2017 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Sell | S | 11.25 | 4,958 | 55,755 | 24,733 | 29.7 K to 24.7 K (-16.70 %) |
Nov 09 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 11.25 | 4,958 | 55,755 | 21,423 | 26.4 K to 21.4 K (-18.79 %) |
Nov 06 2017 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Nov 06 2017 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Buy | M | 0.00 | 15,000 | 0 | 29,691 | 14.7 K to 29.7 K (+102.10 %) |
Nov 06 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Nov 06 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Buy | M | 0.00 | 15,000 | 0 | 26,381 | 11.4 K to 26.4 K (+131.80 %) |
Oct 04 2017 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.26 | 2,000 | 528 | 1,099 | |
Oct 04 2017 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 12.00 | 2,000 | 24,000 | 0 | 2 K to 0 (-100.00 %) |
Oct 04 2017 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.26 | 2,000 | 528 | 2,000 | 0 to 2 K |
Oct 04 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 12.00 | 1,500 | 18,000 | 11,381 | 12.9 K to 11.4 K (-11.65 %) |
Sep 18 2017 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.26 | 2,882 | 761 | 3,099 | |
Sep 18 2017 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 11.00 | 2,882 | 31,702 | 0 | 2.9 K to 0 (-100.00 %) |
Sep 18 2017 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.26 | 2,882 | 761 | 2,882 | 0 to 2.9 K |
Sep 18 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 11.00 | 2,000 | 22,000 | 12,881 | 14.9 K to 12.9 K (-13.44 %) |
Sep 13 2017 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.26 | 118 | 31 | 5,981 | |
Sep 13 2017 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 11.00 | 118 | 1,298 | 0 | 118 to 0 (-100.00 %) |
Sep 13 2017 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.26 | 118 | 31 | 118 | 0 to 118 |
Sep 13 2017 | KPTI | Karyopharm Therape ... | FALVEY MICHAEL | EVP, CFO & Treasure ... | Option Exercise | A | 10.60 | 125,000 | 1,325,000 | 125,000 | |
Sep 01 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 10.03 | 805 | 8,071 | 14,881 | 15.7 K to 14.9 K (-5.13 %) |
Aug 30 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Sell | S | 10.00 | 2,195 | 21,950 | 15,686 | 17.9 K to 15.7 K (-12.28 %) |
Jun 16 2017 | KPTI | Karyopharm Therape ... | WEG KENNETH E | Director | Option Exercise | A | 9.18 | 17,000 | 156,060 | 17,000 | |
Jun 16 2017 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 9.18 | 17,000 | 156,060 | 17,000 | |
Jun 16 2017 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | A | 9.18 | 17,000 | 156,060 | 17,000 | |
Jun 16 2017 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Option Exercise | A | 9.18 | 17,000 | 156,060 | 17,000 | |
Jun 16 2017 | KPTI | Karyopharm Therape ... | Garland J. Scott | Director | Option Exercise | A | 9.18 | 17,000 | 156,060 | 17,000 | |
Jun 16 2017 | KPTI | Karyopharm Therape ... | Dolsten Mikael | Director | Option Exercise | A | 9.18 | 17,000 | 156,060 | 17,000 | |
Jun 16 2017 | KPTI | Karyopharm Therape ... | BOHLIN GAREN G | Director | Option Exercise | A | 9.18 | 17,000 | 156,060 | 17,000 | |
Jan 24 2017 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Option Exercise | A | 10.39 | 100,000 | 1,039,000 | 100,000 | |
Jan 24 2017 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP, OPS, BUS DEV, ... | Option Exercise | A | 10.39 | 118,000 | 1,226,020 | 118,000 | |
Jan 24 2017 | KPTI | Karyopharm Therape ... | Renz Justin A | EVP, CFO & Treasure ... | Option Exercise | A | 10.39 | 100,000 | 1,039,000 | 100,000 | |
Jan 24 2017 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 10.39 | 250,000 | 2,597,500 | 250,000 | |
Jan 24 2017 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 10.39 | 250,000 | 2,597,500 | 250,000 | |
Jan 24 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 10.39 | 250,000 | 2,597,500 | 250,000 | |
Jan 24 2017 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 10.39 | 250,000 | 2,597,500 | 250,000 | |
Nov 15 2016 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Sell | S | 10.06 | 3,309 | 33,286 | 14,691 | 18 K to 14.7 K (-18.38 %) |
Nov 14 2016 | KPTI | Karyopharm Therape ... | Renz Justin A | EVP, CFO & Treasure ... | Sell | S | 8.19 | 4,342 | 35,544 | 19,173 | 23.5 K to 19.2 K (-18.46 %) |
Nov 14 2016 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Sell | S | 8.19 | 4,342 | 35,544 | 15,819 | 20.2 K to 15.8 K (-21.54 %) |
Nov 08 2016 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Option Exercise | M | 0.00 | 15,000 | 0 | 15,000 | |
Nov 08 2016 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Buy | M | 0.00 | 15,000 | 0 | 18,000 | 3 K to 18 K (+500.00 %) |
Nov 08 2016 | KPTI | Karyopharm Therape ... | Renz Justin A | EVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 15,000 | 0 | 15,000 | |
Nov 08 2016 | KPTI | Karyopharm Therape ... | Renz Justin A | EVP, CFO & Treasure ... | Buy | M | 0.00 | 15,000 | 0 | 23,515 | 8.5 K to 23.5 K (+176.16 %) |
Nov 08 2016 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Option Exercise | M | 0.00 | 15,000 | 0 | 15,000 | |
Nov 08 2016 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Buy | M | 0.00 | 15,000 | 0 | 20,161 | 5.2 K to 20.2 K (+290.64 %) |
Jun 27 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.03 | 18,824 | 151,083 | 8,549,920 | 8.6 M to 8.5 M (-0.22 %) |
Jun 17 2016 | KPTI | Karyopharm Therape ... | WEG KENNETH E | Director | Option Exercise | A | 8.06 | 10,000 | 80,600 | 10,000 | |
Jun 17 2016 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 8.06 | 10,000 | 80,600 | 10,000 | |
Jun 17 2016 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | A | 8.06 | 10,000 | 80,600 | 10,000 | |
Jun 17 2016 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Option Exercise | A | 8.06 | 10,000 | 80,600 | 10,000 | |
Jun 17 2016 | KPTI | Karyopharm Therape ... | Garland J. Scott | Director | Option Exercise | A | 8.06 | 10,000 | 80,600 | 10,000 | |
Jun 17 2016 | KPTI | Karyopharm Therape ... | Dolsten Mikael | Director | Option Exercise | A | 8.06 | 10,000 | 80,600 | 10,000 | |
Jun 17 2016 | KPTI | Karyopharm Therape ... | BOHLIN GAREN G | Director | Option Exercise | A | 8.06 | 10,000 | 80,600 | 10,000 | |
Jun 15 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.51 | 7,074 | 60,214 | 8,568,744 | 8.6 M to 8.6 M (-0.08 %) |
Jun 10 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 9.14 | 30,000 | 274,098 | 8,575,818 | 8.6 M to 8.6 M (-0.35 %) |
Jun 10 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 9.34 | 15,541 | 145,186 | 8,605,818 | 8.6 M to 8.6 M (-0.18 %) |
Jun 08 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 9.25 | 20,000 | 185,086 | 8,621,359 | 8.6 M to 8.6 M (-0.23 %) |
Jun 08 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 9.22 | 20,000 | 184,464 | 8,641,359 | 8.7 M to 8.6 M (-0.23 %) |
Jun 06 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 9.65 | 17,855 | 172,244 | 8,661,359 | 8.7 M to 8.7 M (-0.21 %) |
Jun 01 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 9.64 | 17,568 | 169,327 | 8,679,214 | 8.7 M to 8.7 M (-0.20 %) |
Jun 01 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 9.66 | 17,096 | 165,072 | 8,696,782 | 8.7 M to 8.7 M (-0.20 %) |
Jun 01 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 9.58 | 40,000 | 383,200 | 8,713,878 | 8.8 M to 8.7 M (-0.46 %) |
May 27 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 9.59 | 18,182 | 174,287 | 8,753,878 | 8.8 M to 8.8 M (-0.21 %) |
May 27 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 9.83 | 27,940 | 274,541 | 8,772,060 | 8.8 M to 8.8 M (-0.32 %) |
May 23 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.77 | 33,932 | 297,414 | 8,800,000 | 8.8 M to 8.8 M (-0.38 %) |
May 23 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.52 | 40,000 | 340,748 | 8,833,932 | 8.9 M to 8.8 M (-0.45 %) |
May 23 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.18 | 20,000 | 163,644 | 8,873,932 | 8.9 M to 8.9 M (-0.22 %) |
May 19 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.15 | 30,000 | 244,488 | 8,893,932 | 8.9 M to 8.9 M (-0.34 %) |
May 19 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.15 | 33,800 | 275,480 | 8,923,932 | 9 M to 8.9 M (-0.38 %) |
May 17 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.01 | 10,000 | 80,065 | 8,957,732 | 9 M to 9 M (-0.11 %) |
May 17 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.01 | 400 | 3,203 | 8,967,732 | 9 M to 9 M (0.00 %) |
May 12 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.41 | 11,868 | 99,860 | 8,968,132 | 9 M to 9 M (-0.13 %) |
May 12 2016 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 8.14 | 20,000 | 162,788 | 8,980,000 | 9 M to 9 M (-0.22 %) |
Jan 20 2016 | KPTI | Karyopharm Therape ... | Frenkel Ran | Chief Dev Operation ... | Option Exercise | A | 6.54 | 75,000 | 490,500 | 75,000 | |
Jan 20 2016 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Option Exercise | A | 6.54 | 40,000 | 261,600 | 40,000 | |
Jan 20 2016 | KPTI | Karyopharm Therape ... | Renz Justin A | EVP, CFO & Treasure ... | Option Exercise | A | 6.54 | 100,000 | 654,000 | 100,000 | |
Jan 20 2016 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 6.54 | 170,000 | 1,111,800 | 170,000 | |
Jan 20 2016 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 6.54 | 170,000 | 1,111,800 | 170,000 | |
Jan 20 2016 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 6.54 | 170,000 | 1,111,800 | 170,000 | |
Jan 20 2016 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 6.54 | 170,000 | 1,111,800 | 170,000 | |
Dec 10 2015 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.26 | 2,121 | 560 | 6,099 | |
Dec 10 2015 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.03 | 6,061 | 200 | 0 | |
Dec 10 2015 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.03 | 2,556 | 84 | 0 | |
Dec 10 2015 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 15.01 | 6,383 | 95,803 | 0 | 6.4 K to 0 (-100.00 %) |
Dec 10 2015 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.26 | 2,121 | 560 | 6,383 | 4.3 K to 6.4 K (+49.77 %) |
Dec 10 2015 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 15.01 | 6,061 | 90,970 | 4,262 | 10.3 K to 4.3 K (-58.71 %) |
Dec 10 2015 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.03 | 6,061 | 200 | 10,323 | 4.3 K to 10.3 K (+142.21 %) |
Dec 10 2015 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 15.01 | 2,556 | 38,363 | 4,262 | 6.8 K to 4.3 K (-37.49 %) |
Dec 10 2015 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.03 | 2,556 | 84 | 6,818 | 4.3 K to 6.8 K (+59.97 %) |
Nov 09 2015 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, WW Development ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Nov 09 2015 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Nov 09 2015 | KPTI | Karyopharm Therape ... | Renz Justin A | EVP, CFO & Treasure ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Sep 21 2015 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | SVP,CORP DEV,GEN CO ... | Option Exercise | A | 14.94 | 75,000 | 1,120,500 | 75,000 | |
May 26 2015 | KPTI | Karyopharm Therape ... | WEG KENNETH E | Director | Option Exercise | A | 26.15 | 10,000 | 261,500 | 10,000 | |
May 26 2015 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Option Exercise | A | 26.15 | 10,000 | 261,500 | 10,000 | |
May 26 2015 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | A | 26.15 | 10,000 | 261,500 | 10,000 | |
May 26 2015 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Option Exercise | A | 26.15 | 10,000 | 261,500 | 10,000 | |
May 26 2015 | KPTI | Karyopharm Therape ... | Garland J. Scott | Director | Option Exercise | A | 26.15 | 10,000 | 261,500 | 10,000 | |
May 26 2015 | KPTI | Karyopharm Therape ... | Dolsten Mikael | Director | Option Exercise | A | 26.15 | 10,000 | 261,500 | 10,000 | |
May 26 2015 | KPTI | Karyopharm Therape ... | BOHLIN GAREN G | Director | Option Exercise | A | 26.15 | 10,000 | 261,500 | 10,000 | |
Apr 08 2015 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, WW Development ... | Buy | P | 33.00 | 2,000 | 66,000 | 3,000 | 1,000 to 3 K (+200.00 %) |
Apr 08 2015 | KPTI | Karyopharm Therape ... | Frenkel Ran | EVP, WW Development ... | Buy | P | 29.43 | 1,000 | 29,430 | 1,000 | 0 to 1,000 |
Apr 06 2015 | KPTI | Karyopharm Therape ... | Greene Barry E | Director | Buy | P | 29.31 | 3,000 | 87,938 | 3,000 | 0 to 3 K |
Apr 06 2015 | KPTI | Karyopharm Therape ... | Renz Justin A | EVP, CFO & Treasure ... | Buy | P | 29.71 | 5,000 | 148,557 | 5,000 | 0 to 5 K |
Apr 06 2015 | KPTI | Karyopharm Therape ... | WEG KENNETH E | Director | Grant | A | 29.55 | 5,000 | 147,760 | 5,000 | 0 to 5 K |
Apr 02 2015 | KPTI | Karyopharm Therape ... | Dolsten Mikael | Director | Option Exercise | A | 30.61 | 20,000 | 612,200 | 20,000 | |
Jan 22 2015 | KPTI | Karyopharm Therape ... | Primiano Christopher Brett | VP, GEN COUNSEL & S ... | Option Exercise | A | 26.65 | 125,000 | 3,331,250 | 125,000 | |
Jan 22 2015 | KPTI | Karyopharm Therape ... | Renz Justin A | EVP, CFO & Treasure ... | Option Exercise | A | 26.65 | 45,000 | 1,199,250 | 45,000 | |
Jan 22 2015 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 26.65 | 200,000 | 5,330,000 | 200,000 | |
Jan 22 2015 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Option Exercise | A | 26.65 | 200,000 | 5,330,000 | 200,000 | |
Jan 22 2015 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 26.65 | 200,000 | 5,330,000 | 200,000 | |
Jan 22 2015 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 26.65 | 200,000 | 5,330,000 | 200,000 | |
Jan 14 2015 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 33.00 | 25,000 | 825,000 | 562,596 | 587.6 K to 562.6 K (-4.25 %) |
Jan 14 2015 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Sell | S | 33.00 | 25,000 | 825,000 | 763,963 | 789 K to 764 K (-3.17 %) |
Jan 14 2015 | KPTI | Karyopharm Therape ... | Shacham Sharon | President & CSO | Gift | G | 0.00 | 20,000 | 0 | 788,963 | 809 K to 789 K (-2.47 %) |
Jan 14 2015 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 33.00 | 440 | 14,520 | 21,883 | 21.4 K to 21.9 K (+2.05 %) |
Jan 14 2015 | KPTI | Karyopharm Therape ... | PAKIANATHAN DEEPIKA | Director | Buy | P | 33.00 | 45,014 | 1,485,462 | 2,241,123 | 2.2 M to 2.2 M (+2.05 %) |
Jan 14 2015 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 33.00 | 25,000 | 825,000 | 763,963 | 789 K to 764 K (-3.17 %) |
Jan 14 2015 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 33.00 | 25,000 | 825,000 | 562,596 | 587.6 K to 562.6 K (-4.25 %) |
Jan 14 2015 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Gift | G | 0.00 | 20,000 | 0 | 788,963 | 809 K to 789 K (-2.47 %) |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.03 | 5,000 | 165 | 2,555 | |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Option Exercise | M | 0.03 | 1,535 | 51 | 7,555 | |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 45.18 | 5,000 | 225,881 | 4,262 | 9.3 K to 4.3 K (-53.98 %) |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.03 | 5,000 | 165 | 9,262 | 4.3 K to 9.3 K (+117.32 %) |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Sell | S | 41.86 | 5,000 | 209,286 | 4,262 | 9.3 K to 4.3 K (-53.98 %) |
Dec 03 2014 | KPTI | Karyopharm Therape ... | Mirza Mansoor Raza | Director | Buy | M | 0.03 | 1,535 | 51 | 9,262 | 7.7 K to 9.3 K (+19.87 %) |
Dec 01 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 41.76 | 198,115 | 8,273,223 | 9,132,700 | 9.3 M to 9.1 M (-2.12 %) |
Dec 01 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.18 | 25,000 | 1,054,520 | 9,330,815 | 9.4 M to 9.3 M (-0.27 %) |
Dec 01 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.74 | 4,094 | 174,992 | 9,355,815 | 9.4 M to 9.4 M (-0.04 %) |
Dec 01 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.35 | 50,906 | 2,155,925 | 9,360 | 60.3 K to 9.4 K (-84.47 %) |
Nov 25 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 44.03 | 10,501 | 462,410 | 9,410,815 | 9.4 M to 9.4 M (-0.11 %) |
Nov 25 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 43.54 | 61,326 | 2,670,373 | 9,421,316 | 9.5 M to 9.4 M (-0.65 %) |
Nov 25 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 42.51 | 53,173 | 2,260,320 | 9,482,642 | 9.5 M to 9.5 M (-0.56 %) |
Nov 25 2014 | KPTI | Karyopharm Therape ... | Chione Ltd | 10% Owner | Sell | S | 41.78 | 75,000 | 3,133,800 | 9,535,815 | 9.6 M to 9.5 M (-0.78 %) |